Yousef Zakharia: Combining hypomethylating agent guadecitabine and IO in ccRCC

Yousef Zakharia, Associate Professor of Medicine at The University of Iowa shared a post on X:

“Thrilled to share our clinical trial conducted though Big Ten Cancer Research Consortium in Nature Communications combining hypomethylating agent guadecitabine and IO in ccRCC. Huge team effort in conducting and publishing this IIT.”

Read further.
Source: Yousef Zakharia/X